Smith & Nephew plc (NYSE:SNN) Shares Sold by Inspire Advisors LLC

Inspire Advisors LLC lessened its stake in shares of Smith & Nephew plc (NYSE:SNN) by 2.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 21,693 shares of the medical equipment provider’s stock after selling 593 shares during the period. Inspire Advisors LLC’s holdings in Smith & Nephew were worth $676,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of SNN. Bank of Montreal Can raised its position in shares of Smith & Nephew by 355.8% during the 2nd quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock worth $31,059,000 after purchasing an additional 964,762 shares during the last quarter. Brandes Investment Partners LP raised its position in shares of Smith & Nephew by 20.5% during the 2nd quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock worth $34,002,000 after purchasing an additional 233,293 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Smith & Nephew by 58.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock valued at $12,995,000 after acquiring an additional 193,046 shares during the last quarter. Tocqueville Asset Management L.P. raised its holdings in Smith & Nephew by 294.9% in the 1st quarter. Tocqueville Asset Management L.P. now owns 224,441 shares of the medical equipment provider’s stock valued at $5,692,000 after acquiring an additional 167,599 shares during the last quarter. Finally, Deprince Race & Zollo Inc. raised its holdings in Smith & Nephew by 94.2% in the 2nd quarter. Deprince Race & Zollo Inc. now owns 239,245 shares of the medical equipment provider’s stock valued at $5,928,000 after acquiring an additional 116,078 shares during the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Stock Performance

Smith & Nephew stock opened at $29.56 on Friday. The firm has a 50 day simple moving average of $30.37 and a 200-day simple moving average of $27.51. Smith & Nephew plc has a 1-year low of $21.52 and a 1-year high of $31.72. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. The stock has a market cap of $12.92 billion, a price-to-earnings ratio of 14.21, a price-to-earnings-growth ratio of 1.25 and a beta of 0.82.

Analysts Set New Price Targets

A number of analysts have commented on the stock. StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Monday, August 5th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Smith & Nephew in a report on Wednesday, July 24th. They issued a “buy” rating for the company. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy”.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.